Identification of molecular hinge points mediating alternating access in the vesicular monoamine transporter VMAT2

被引:39
|
作者
Yaffe, Dana [1 ]
Radestock, Sebastian [2 ]
Shuster, Yonatan [1 ]
Forrest, Lucy R. [2 ]
Schuldiner, Shimon [1 ]
机构
[1] Hebrew Univ Jerusalem, Alexander A Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel
[2] Max Planck Inst Biophys, Computat Struct Biol Grp, D-60438 Frankfurt, Germany
基金
美国国家卫生研究院;
关键词
ion coupling; multidrug resistance; membrane proteins; neurotransmitter transporter; homology modeling; MAJOR FACILITATOR SUPERFAMILY; ESCHERICHIA-COLI; NEUROTRANSMITTER TRANSPORTERS; LACTOSE PERMEASE; ACETYLCHOLINE TRANSPORTER; MULTIDRUG TRANSPORTER; MUTATIONAL ANALYSIS; OXALOBACTER-FORMIGENES; FACING CONFORMATION; SEQUENCE ALIGNMENT;
D O I
10.1073/pnas.1220497110
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Vesicular monoamine transporter 2 (VMAT2) catalyzes transport of monoamines into storage vesicles in a process that involves exchange of the charged monoamine with two protons. VMAT2 is a member of the DHA12 family of multidrug transporters that belongs to the major facilitator superfamily (MFS) of secondary transporters. Here we present a homology model of VMAT2, which has the standard MFS fold, that is, with two domains of six transmembrane helices each which are related by twofold pseudosymmetry and whose axis runs normal to the membrane and between the two halves. Demonstration of the essential role of a membrane-embedded glutamate and confirmation of the existence of a hydrogen bond probably involved in proton transport provide experimental evidence that validates some of the predictions inherent to the model. Moreover, we show the essential role of residues at two anchor points between the two bundles. These residues appear to function as molecular hinge points about which the two six transmembrane-helix bundles flex and straighten to open and close the pathways on either side of the membrane as required for transport. Polar residues that create a hydrogen bond cluster form one of the anchor points of VMAT2. The other results from hydrophobic interactions. Residues at the anchor points are strongly conserved in other MFS transporters in one way or another, suggesting that interactions at these locations will be critical in most, if not all, MFS transporters.
引用
收藏
页码:E1332 / E1341
页数:10
相关论文
共 50 条
  • [21] In Vivo Evidence for Low Striatal Vesicular Monoamine Transporter 2 (VMAT2) Availability in Cocaine Abusers
    Narendran, Rajesh
    Lopresti, Brian J.
    Martinez, Diana
    Mason, Neale Scott
    Nimes, Michael
    May, Maureen A.
    Daley, Dennis C.
    Price, Julie C.
    Mathis, Chester A.
    Frank, W. Gordon
    AMERICAN JOURNAL OF PSYCHIATRY, 2012, 169 (01): : 55 - 63
  • [22] Vesicular monoamine transporter 2 (Vmat2) knockdown elicits anxiety-like behavior in zebrafish
    Wang, Yali
    Li, Siyue
    Liu, Wenwen
    Wang, Fen
    Hu, Li-Fang
    Zhong, Zhao-min
    Wang, Han
    Liu, Chun-Feng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 470 (04) : 792 - 797
  • [23] Tardive dyskinesia: placing vesicular monoamine transporter type 2 (VMAT2) inhibitors into clinical perspective
    Citrome, Leslie
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2018, 18 (04) : 323 - 332
  • [24] Relationship between vesicular monoamine transporter 2 (VMAT2) expression and insulin expression in human pancreas
    Saisho, Yoshifumi
    Butler, Alexandra E.
    Monchamp, Travis
    Galasso, Ryan
    Gurlo, Tatyana
    Harris, Paul E.
    Rizza, Roberta.
    Butler, Peter C.
    DIABETES, 2008, 57 : A46 - A47
  • [25] LOCALIZATION OF VESICULAR MONOAMINE TRANSPORTER ISOFORMS (VMAT1 AND VMAT2) TO ENDOCRINE-CELLS AND NEURONS IN RAT
    WEIHE, E
    SCHAFER, MKH
    ERICKSON, JD
    EIDEN, LE
    JOURNAL OF MOLECULAR NEUROSCIENCE, 1994, 5 (03) : 149 - 164
  • [26] No Differential Regulation of Dopamine Transporter (DAT) and Vesicular Monoamine Transporter 2 (VMAT2) Binding in a Primate Model of Parkinson Disease
    Tian, LinLin
    Karimi, Morvarid
    Loftin, Susan K.
    Brown, Chris A.
    Xia, HuChuan
    Xu, JinBin
    Mach, Robert H.
    Perlmutter, Joel S.
    PLOS ONE, 2012, 7 (02):
  • [27] Narcolepsy: involvement of imprinted, differentially-methylated promotor haplotypes of vesicular monoamine transporter 2 (VMAT2).
    Drgon, T
    Takahashi, M
    Walther, D
    Lin, Z
    Lin, L
    Tafti, M
    Billiard, M
    Thorpy, M
    Temple, H
    Montplaisir, J
    Mignot, E
    Uhl, GR
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 332 - 332
  • [28] Interaction of vesicular monoamine transporter 2 (VMAT2) and neuromelanin pigment among the midbrain dopaminergic neurons in man
    Pasbakhsh, P.
    German, D.
    VIRCHOWS ARCHIV, 2010, 457 (02) : 239 - 239
  • [29] Inhibitors of vesicular monoamine transporter type 2 (VMAT2) and the risk of anxiety and depression: meta-analysis
    Szejko, N.
    Cuenod, M.
    Macul Ferreira de Barros, P.
    Artukoglu, B.
    Flores, J.
    Nasir, M.
    Bloch, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 625 - 625
  • [30] Striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice: voltammetric assessment
    Patel, J
    Mooslehner, KA
    Chan, PM
    Emson, PC
    Stamford, JA
    MONITORING MOLECULES IN NEUROSCIENCE, 2001, : 253 - 254